Insmed Inc (NASDAQ: INSM) is 12.75% higher on its value in year-to-date trading and has touched a low of $21.92 and a high of $80.53 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The INSM stock was last observed hovering at around $78.45 in the last trading session, with the day’s loss setting it -0.61%.
Currently trading at $77.84, the stock is 10.53% and 8.59% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.79 million and changing -0.78% at the moment leaves the stock 23.27% off its SMA200. INSM registered 172.84% gain for a year compared to 6-month loss of 2.43%. The firm has a 50-day simple moving average (SMA 50) of $71.5622 and a 200-day simple moving average (SMA200) of $62.89535.
The stock witnessed a 12.15% gain in the last 1 month and extending the period to 3 months gives it a 7.69%, and is 10.88% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.02% over the week and 3.79% over the month.
Insmed Inc (INSM) has around 912 employees, a market worth around $13.93B and $342.96M in sales. Profit margin for the company is -252.01%. Distance from 52-week low is 255.11% and -3.34% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.93%).
with sales reaching $97.96M over the same period.The EPS is expected to shrink by -0.40% this year, but quarterly earnings will post 17.24% year-over-year. Quarterly sales are estimated to grow 17.04% in year-over-year returns.
568.0 institutions hold shares in Insmed Inc (INSM), with institutional investors hold 112.98% of the company’s shares. The shares outstanding are 178.85M, and float is at 174.62M with Short Float at 8.84%. Institutions hold 111.95% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 16.01 million shares valued at $1.07 billion. The investor’s holdings represent 10.7864 of the INSM Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.26 million shares valued at $955.72 million to account for 9.6086 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 12.16 million shares representing 8.1932 and valued at over $814.95 million, while FMR LLC holds 4.9207 of the shares totaling 7.31 million with a market value of $489.44 million.
Insmed Inc (INSM) Insider Activity
The most recent transaction is an insider sale by Flammer Martina M.D., the company’s Chief Medical Officer. SEC filings show that Flammer Martina M.D. sold 1,384 shares of the company’s common stock on Jan 14 ’25 at a price of $68.72 per share for a total of $95108.0. Following the sale, the insider now owns 0.1 million shares.
Insmed Inc disclosed in a document filed with the SEC on Jan 14 ’25 that Adsett Roger (Chief Operating Officer) sold a total of 1,457 shares of the company’s common stock. The trade occurred on Jan 14 ’25 and was made at $68.72 per share for $0.1 million. Following the transaction, the insider now directly holds 0.15 million shares of the INSM stock.
Still, SEC filings show that on Jan 14 ’25, Schaeffer Orlov S Nicole (Chief People Strategy Officer) disposed off 872 shares at an average price of $68.72 for $59924.0. The insider now directly holds 97,083 shares of Insmed Inc (INSM).
